Hi nashezz,
Yes I noticed that Triton fund recently purchased.
Interesting points you make, should we be looking at the size of the Pharma company. Jon has sort of pointed out it is unlikely to be a big Pharma company, so I had sort of expected small co. perhaps 1-2 deals?
I thought their focus and experience in distribution globally the key feature that was most appealing to me, of coarse the upfront $$ value and % royalty structure is also important detail, but the size of the co not so much.
ROW Rights, page-35
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |